Literature DB >> 17921248

A mouse model of conditional lipodystrophy.

Suyeon Kim1, Li-Wen Huang, Kathy J Snow, Vitaly Ablamunits, Muneer G Hasham, Timothy H Young, Angelique C Paulk, Joel E Richardson, Jason P Affourtit, Tali Shalom-Barak, Carol J Bult, Yaacov Barak.   

Abstract

Lipodystrophies are syndromes of adipose tissue degeneration associated with severe defects in lipid and glucose homeostasis. We report here the generation and analysis of Pparg(ldi), a targeted allele that confers conditional dominant lipodystrophy in mice. The Pparg(ldi) allele was generated by insertion of the Tet activator (tTA) and a tTA-regulated Flag-Pparg1 transgene into the Pparg gene. Unexpectedly, tTA elicits mild lipodystrophy, insulin resistance, and dyslipidemia, and the Flag-PPARgamma1 transgene surprisingly exacerbates these traits. Doxycycline can both completely prevent and reverse these phenotypes, providing a mouse model of inducible lipodystrophy. Embryonic fibroblasts from either Pparg(ldi/+) or the phenotypically similar aP2-nSrebp1c (Sr) transgenic mice undergo robust adipogenesis, suggesting that neither strain develops lipodystrophy because of defective adipocyte differentiation. In addition, Pparg(ldi/+) adipose tissue shares extensive gene expression aberrations with that of Sr mice, authenticating the phenotype at the molecular level and revealing a common expression signature of lipodystrophic fat. Thus, the Pparg(ldi/+) mouse provides a conditional animal model for studying lipodystrophy and its associated physiology and gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921248      PMCID: PMC2034232          DOI: 10.1073/pnas.0707797104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

Review 2.  Using ANOVA to analyze microarray data.

Authors:  Gary A Churchill
Journal:  Biotechniques       Date:  2004-08       Impact factor: 1.993

Review 3.  Acquired and inherited lipodystrophies.

Authors:  Abhimanyu Garg
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

4.  PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.

Authors:  Robert A Hegele; Henian Cao; Christy Frankowski; Suresh T Mathews; Todd Leff
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.

Authors:  Alberto M Pendás; Zhongjun Zhou; Juan Cadiñanos; José M P Freije; Jianming Wang; Kjell Hultenby; Aurora Astudillo; Annika Wernerson; Francisco Rodríguez; Karl Tryggvason; Carlos López-Otín
Journal:  Nat Genet       Date:  2002-04-01       Impact factor: 38.330

6.  Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse.

Authors:  Takeshi Imai; Reiko Takakuwa; Sandra Marchand; Emilie Dentz; Jean-Marc Bornert; Nadia Messaddeq; Olivia Wendling; Manuel Mark; Béatrice Desvergne; Walter Wahli; Pierre Chambon; Daniel Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-16       Impact factor: 11.205

7.  Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

Authors:  Weimin He; Yaacov Barak; Andrea Hevener; Peter Olson; Debbie Liao; Jamie Le; Michael Nelson; Estelita Ong; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

8.  Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.

Authors:  Karim El-Haschimi; Scott D Dufresne; Michael F Hirshman; Jeffrey S Flier; Laurie J Goodyear; Christian Bjørbaek
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

9.  The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis.

Authors:  Sarah Hummasti; Peter Tontonoz
Journal:  Mol Endocrinol       Date:  2006-03-23

10.  Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice.

Authors:  Palle G Laustsen; M Dodson Michael; Barbara E Crute; Shmuel E Cohen; Kohjiro Ueki; Rohit N Kulkarni; Susanna R Keller; Gustav E Lienhard; C Ronald Kahn
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

View more
  20 in total

1.  DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria.

Authors:  Ismene Karakasilioti; Irene Kamileri; Georgia Chatzinikolaou; Theodoros Kosteas; Eleni Vergadi; Andria Rasile Robinson; Iannis Tsamardinos; Tania A Rozgaja; Sandra Siakouli; Christos Tsatsanis; Laura J Niedernhofer; George A Garinis
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

2.  The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity.

Authors:  Maria Namwanje; Longhua Liu; Michelle Chan; Nikki Aaron; Michael J Kraakman; Li Qiang
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

3.  Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.

Authors:  Tali Shalom-Barak; Jaclyn Liersemann; Babak Memari; Lawrence Flechner; Caitlin E Devor; Tiffany M Bernardo; Suyeon Kim; Nobuyuki Matsumoto; Scott L Friedman; Ronald M Evans; John H White; Yaacov Barak
Journal:  Mol Cell Biol       Date:  2018-04-16       Impact factor: 4.272

4.  Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.

Authors:  Roberta Goncalves Marangoni; Benjamin D Korman; Jun Wei; Tammara A Wood; Lauren V Graham; Michael L Whitfield; Philipp E Scherer; Warren G Tourtellotte; John Varga
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

5.  PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.

Authors:  Jun Wei; Asish K Ghosh; Jennifer L Sargent; Kazuhiro Komura; Minghua Wu; Qi-Quan Huang; Manu Jain; Michael L Whitfield; Carol Feghali-Bostwick; John Varga
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

Review 6.  Pancreatic Islet Responses to Metabolic Trauma.

Authors:  Susan J Burke; Michael D Karlstad; J Jason Collier
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

7.  Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network.

Authors:  Tali Shalom-Barak; Xiaowen Zhang; Tianjiao Chu; W Timothy Schaiff; Janardan K Reddy; Jianming Xu; Yoel Sadovsky; Yaacov Barak
Journal:  Dev Biol       Date:  2012-08-29       Impact factor: 3.582

Review 8.  Adipose proteome analysis: focus on mediators of insulin resistance.

Authors:  Xiaoli Chen; Sonja Hess
Journal:  Expert Rev Proteomics       Date:  2008-12       Impact factor: 3.940

9.  Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice.

Authors:  J M Arbones-Mainar; L A Johnson; M K Altenburg; N Maeda
Journal:  Int J Obes (Lond)       Date:  2008-08-26       Impact factor: 5.095

10.  Esrrb-Cre excises loxP-flanked alleles in early four-cell embryos.

Authors:  Sungeun Lee; Srinivas R Pallerla; Suyeon Kim; Benjamin Shaffer; Calvin R Simerly; J Richard Chaillet; Yaacov Barak
Journal:  Genesis       Date:  2015-12-28       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.